The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma
Open accessAbstract
The usefulness of measurements of serum α-fetoprotein elevation for diagnosis of the development of hepatocellular carcinoma was evaluated by a prospective study of 260 patients with cirrhosis. Hepatocellular carcinoma was found in 55 patients during the 5-yr follow-up, excluding 7 found to have hepatocellular carcinoma in the first 6 mo. The cumulative incidence of hepatocellular carcinoma was 26 in the 185 patients who had α-fetoprotein levels below 20 ng/ml at the time of entry and 46 in the 68 patients who had α-fetoprotein levels of 20 ng/ml or more but below 200 ng/ml. In 169 of the patients, serum levels of α-fetoprotein were assayed regularly for at least 2 yr. The incidence of hepatocellular carcinoma development in the 36 patients who had repeated transient increases in α-fetoprotein to above 100 ng/ml was 36. This was significantly higher than the incidence in the 99 patients who had α-fetoprotein levels consistently below 20 ng/ml. Thus patients who had α-fetoprotein levels of 20 ng/ml or more, who had transient increases in α-fetoprotein or who had both should be treated as being in a super-high-risk group for hepatocellular carcinoma. Frequent and careful examination by ultrasonography of such patients is recommended. (Hepatology 1994;19:61-66).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis
Oka, H., Kurioka, N., Kim, K., Kanno, T., Kuroki, T., Mizoguchi, Y., & Kobayashi, K. (1990) · Hepatology · doi:10.1002/hep.1840120411 · Cited by 392
Self-citationNomura, F., Ohnishi, K., & Tanabe, Y. (1989) · Cancer · doi:10.1002/1097-0142(19891015)64:8<1700::aid-cncr2820640824>3.0.co;2-z · Cited by 305
Taketa, K., Sekiya, C., Namiki, M., 赤松, 興., Ohta, Y., Endo, Y., & Kosaka, K. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91034-4 · Cited by 212
Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen, D., Sung, J., Sheu, J., Lai, M., How, S.-W., Hsu, H., Lee, C., & Wei, T. (1984) · PubMed · Cited by 202
Aoyagi, Y., Suzuki, Y., Isemura, M., Nomoto, M., Sekine, C., Igarashi, K., & Ichida, F. (1988) · Cancer · doi:10.1002/1097-0142(19880215)61:4<769::aid-cncr2820610422>3.0.co;2-m · Cited by 162
Plasma abnormal prothrombin (Des-γ-carboxy prothrombin) as a marker of hepatocellular carcinoma
Fujiyama, S., Morishita, T., Hashiguchi, O., & Sato, T. (1988) · Cancer · doi:10.1002/1097-0142(19880415)61:8<1621::aid-cncr2820610820>3.0.co;2-c · Cited by 116
Lee, H., Chung, Y., & Kim, C. Y. (1991) · Hepatology · doi:10.1002/hep.1840140112 · Cited by 98
Cited by
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Lok, A. S., Sterling, R. K., Everhart, J. E., Wright, E. C., Hoefs, J. C., Di Bisceglie, A. M., Morgan, T. R., Kim, H., Lee, W. M., Bonkovsky, H. L., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.031 · Cited by 558
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
Velázquez, R. F., Rodríguez, M., Navascués, C. A., Linares, A., Pérez, R., Sotorríos, N. G., Martínez, I., & Rodrigo, L. (2003) · Hepatology · doi:10.1053/jhep.2003.50093 · Cited by 440
Dufour, D. R., Lott, J. A., Nolte, F. S., Gretch, D. R., Koff, R. S., & Seeff, L. B. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.2050 · Cited by 439
Metadata
- Authors
- Oka, H., Tamori, A., Kuroki, T., Kobayashi, K., & Yamamoto, S.
- Venue
- Hepatology
- Published
- 1994-01
- Volume
- 19
- Issue
- 1
- Pages
- 61-66
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2148436793
- Cited by
- 370
- References
- 9
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. https://app.cochat.ai/papers/10.1002/hep.1840190111
- The paper
- Oka, H., Tamori, A., Kuroki, T., Kobayashi, K., & Yamamoto, S. (1994). Prospective study of α-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology. https://doi.org/10.1002/hep.1840190111
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.